Biography

Dr. Yan An Wang, M.D., Ph.D., Professorship in Stomatology,Doctoral supervisor.He received his doctoral degree (M.D. and Ph.D.) fromShanghai Jiao Tong University School of Medicine.

Dr. Wang has worked on oral and maxillofacial surgery for more than 25 years. He has been appointed as a chief physician, hecurrently works as a professor at Shanghai Ninth People’s Hospital. Dr. Wang is expert at surgical treatment of various benign and malignant tumors, repair and reconstruction of tissue defects in the oral and maxilla-facial area, and minimally invasive treatment of hemangiomas, vascular and lymphatic malformations. He sees patients in the clinic ofDepartment of Oral Maxillofacial-Head and Neck Oncology. At present, Dr. Wang is a member of the Oral and Maxillofacial Surgery Committee of Shanghai Oral Medical Association, a member of the Oral and Maxillofacial-Head and Neck Tumor Committee of Shanghai Oral Medical Association, and a member of the Oral Genetic Disease and Rare Disease Committee of Shanghai Oral Medical Association.

Dr. Wang’s scientific contributions began at Shanghai Jiao Tong University School of Medicine, where he initiated his Ph.D.. His first research interest lies in the pathogenesismechanism research and clinical therapy of benign/malignant tumors of the oral and maxillofacial region.He also developed an interest in clinical and molecular mechanism ofcongenital hereditary diseases, such as vascular malformation and neurofibromatosis type 1(NF1). As a further extension of his doctoral work,Dr. Wang was obsessed with tackling the crosstalk between vascular endothelial cellsand smooth muscle cells, a novel mechanism, which exerts an essential role in the development of venous malformation. In the field of oral squamous cell carcinoma, he reveals the fundamental function of tumor inflammatory microenvironment to cancer stemness and EMT phenotype. While focusing on neurofibromatosis, he currently aims toelaborate the crosstalk between schwann cell and fibroblast which is a key mechanism to collagen deposit and might be a potential therapeutic target for the treatment of NF1-related neurofibroma. Based on these studies above, Dr. Wang has published 34 papers (including 25 SCI papers) as corresponding author or the first author. Previously, He was awarded the second prize of National Science and Technology Progress Award and the first prize of Shanghai Science and Technology Progress Award. He is an associate editor of one monograph and a co-editor/translator of six monographs. Dr. Wang presided over two projects of the National Natural Science Foundation of China and participated in seven projects of National Natural Science Foundation of China.